Dec 7 (Reuters) - Cellular Biomedicine Group Inc  CBMG.O :
    * CELLULAR BIOMEDICINE GROUP PRESENTS FIRST CLINICAL DATA OF
IIT
PHASE 1 TRIAL OF C-CAR088, A NOVEL BCMA CAR-T, AT THE 61ST
ANNUAL MEETING OF THE AMERICAN SOCIETY OF HEMATOLOGY
    * CELLULAR BIOMEDICINE GROUP-FIVE PATIENTS INCLUDED IN
ANALYSIS;
ALL FIVE SHOWED CLINICAL IMPROVEMENT IN AS EARLY AS TWO WEEKS

Source text for Eikon:  ID:nPn8V06DGa 
Further company coverage:  CBMG.O 

 ((Reuters.Briefs@thomsonreuters.com;))